Blood draws used for cultures to diagnose bloodstream infections are routinely contaminated at a rate of roughly 2 percent to 3 percent. A device from Seattle-based start up Magnolia Medical Technologies Inc. has been found in a recent study to reduce that contamination rate to 0.2 percent, which could save billions and improve patient care with broad implementation.